Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$122.0 - $145.31 $244 - $290
2 Added 3.57%
58 $7,000
Q2 2023

Aug 11, 2023

BUY
$122.5 - $147.16 $2,695 - $3,237
22 Added 64.71%
56 $6,000
Q1 2023

May 11, 2023

BUY
$133.98 - $160.47 $3,751 - $4,493
28 Added 466.67%
34 $4,000
Q4 2022

Feb 13, 2023

BUY
$129.72 - $159.85 $389 - $479
3 Added 100.0%
6 $0
Q3 2022

Nov 10, 2022

BUY
$126.59 - $161.18 $379 - $483
3 New
3 $0
Q1 2020

May 14, 2020

SELL
$87.74 - $152.74 $21 Million - $36.5 Million
-239,080 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$117.65 - $153.73 $60.2 Million - $78.7 Million
-511,868 Reduced 68.16%
239,080 $35.7 Million
Q3 2019

Nov 13, 2019

SELL
$125.18 - $143.24 $5.01 Million - $5.73 Million
-40,004 Reduced 5.06%
750,948 $96.2 Million
Q2 2019

Aug 13, 2019

SELL
$125.55 - $144.48 $1.82 Million - $2.09 Million
-14,457 Reduced 1.79%
790,952 $113 Million
Q1 2019

May 13, 2019

SELL
$121.81 - $142.95 $4.43 Million - $5.2 Million
-36,358 Reduced 4.32%
805,409 $115 Million
Q4 2018

Feb 13, 2019

BUY
$115.94 - $166.74 $1.05 Million - $1.51 Million
9,067 Added 1.09%
841,767 $104 Million
Q3 2018

Nov 09, 2018

SELL
$161.01 - $180.57 $2.8 Million - $3.14 Million
-17,366 Reduced 2.04%
832,700 $140 Million
Q2 2018

Aug 10, 2018

SELL
$146.33 - $183.18 $8.59 Million - $10.7 Million
-58,671 Reduced 6.46%
850,066 $146 Million
Q1 2018

May 14, 2018

BUY
$135.59 - $157.16 $1.21 Million - $1.4 Million
8,935 Added 0.99%
908,737 $137 Million
Q4 2017

Feb 12, 2018

BUY
$131.06 - $150.39 $1.04 Million - $1.19 Million
7,926 Added 0.89%
899,802 $121 Million
Q3 2017

Nov 13, 2017

SELL
$142.62 - $155.6 $27.4 Million - $29.9 Million
-192,328 Reduced 17.74%
891,876 $130 Million
Q2 2017

Aug 29, 2017

BUY
N/A
1,084,204
1,084,204 $169 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.